Top Markets
Coin of the day
Yumanity Therapeutics, Inc. Yumanity Therapeutics, Inc.

Yumanity Therapeutics, Inc.

YMTX
Pozycja w akcjach #28846
Yumanity Therapeutics Inc. operates as a clinical-stage biopharmaceutical... Yumanity Therapeutics Inc. operates as a clinical-stage biopharmaceutical company. Its primary focus lies in the investigation and development of therapeutic solutions for neurodegenerative conditions, particularly those driven by protein misfolding. The firm aims to discover disease-modifying treatments for a range of neurodegenerative disorders, including Parkinson's disease, dementia with Lewy bodies, multiple system atrophy, amyotrophic lateral sclerosis (ALS), and frontotemporal lobar degeneration. Central to its pipeline is YTX-7739, an innovative small molecule presently in Phase I clinical trials for Parkinson's disease and associated α-synuclein disorders. Additionally, YTX-9184 is undergoing preclinical studies with the goal of treating diverse neurological conditions. The company maintains a license and research collaboration agreement with Merck Sharp & Dohme Corp. Founded in 2014, Yumanity Therapeutics Inc. is headquartered in Boston, Massachusetts.
Cena akcji
$1.89
Ostatnia synchronizacja: 2022-12-16
Kapitalizacja rynkowa
$24.38M
Zmiana (1 dzień)
8.62%
Zmiana (1 rok)
0.00%
Kraj
US
Handel Yumanity Therapeutics, Inc. (YMTX)

Kategoria

Historia ceny akcji dla Yumanity Therapeutics, Inc. (YMTX)
Najwyższa cena zamknięcia: $1.94 dnia 2022-12-01

Najniższa cena zamknięcia: $18.35 dnia 2020-12-01
Historia cen akcji firmy Yumanity Therapeutics, Inc. od 2020 do 2026
Roczna wydajność ceny akcji
Rok Wydajność
2022 -41.89%
2021 -81.82%
2020 0.00%
Cena akcji podobnych firm lub konkurencji
Firma Cena akcji Zmiana 1r% Kraj
$551.16 41.05%
US
$163.88 487.17%
US
$1.03K 57.08%
NL
$117.42 -19.34%
AU
$753.28 8.59%
CH